Related Experiment Video
Updated: May 25, 2026
09:48
Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
Insulin-sensitizing properties of adiponectin
Justine M Tishinsky1, Lindsay E Robinson, David J Dyck
1Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada N1G2W1.
Biochimie
|February 9, 2012
Summary
Adiponectin administration enhances glucose tolerance by reducing liver glucose production and improving muscle glucose uptake. However, the role of adiponectin resistance in muscle insulin response requires further investigation.
Area of Science:
- Endocrinology
- Metabolic Research
- Molecular Biology
Background:
- Adiponectin administration improves glucose tolerance in rodents by affecting hepatic glucose production and skeletal muscle glucose disposal.
- Adiponectin's effects are mediated by AMP-activated protein kinase (AMPK) activation, influencing gluconeogenesis, fatty acid oxidation, and lipid deposition.
- Adiponectin also stimulates mitochondrial biogenesis via AMPK-independent pathways.
Purpose of the Study:
- To investigate the mechanisms underlying impaired adiponectin response in liver and muscle during obesity and insulin resistance.
- To clarify the significance of adiponectin resistance in muscle, particularly in relation to insulin response and lipid accumulation.
Main Methods:
- Rodent models of obesity and insulin resistance were utilized.
- High-fat feeding protocols were employed to induce metabolic dysfunction.
- Assessment of adiponectin response, intramuscular lipid accumulation, and insulin sensitivity in skeletal muscle.
Main Results:
- Obesity and insulin resistance are associated with reduced circulating adiponectin and resistance to its effects in liver and muscle.
- Adiponectin resistance in muscle precedes intramuscular lipid accumulation and impaired insulin response in high-fat fed rodents.
- Restoration of adiponectin response in muscle was not necessary to restore insulin response.
Conclusions:
- The cellular mechanisms driving adiponectin resistance need further elucidation.
- The precise importance of addressing adiponectin resistance for therapeutic interventions remains unclear and warrants additional research.
Related Concept Videos
01:28Insulin: The Receptor and Signaling Pathways
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but this inhibition is released...
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:05Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...